Brokerages expect Alcentra Capital Corp. (NASDAQ:ABDC) to post $0.36 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Alcentra Capital Corp.’s earnings. The lowest EPS estimate is $0.34 and the highest is $0.37. Alcentra Capital Corp. posted earnings of $0.44 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 18.2%. The company is expected to announce its next earnings results on Thursday, August 3rd.
On average, analysts expect that Alcentra Capital Corp. will report full-year earnings of $1.42 per share for the current financial year, with EPS estimates ranging from $1.39 to $1.48. For the next year, analysts forecast that the company will report earnings of $1.50 per share, with EPS estimates ranging from $1.38 to $1.60. Zacks’ EPS averages are a mean average based on a survey of research analysts that that provide coverage for Alcentra Capital Corp..
ABDC has been the topic of a number of analyst reports. Keefe, Bruyette & Woods initiated coverage on Alcentra Capital Corp. in a report on Tuesday, April 11th. They issued a “market perform” rating and a $14.00 price target on the stock. TheStreet raised Alcentra Capital Corp. from a “c” rating to a “b-” rating in a research report on Monday, April 3rd. Raymond James Financial, Inc. cut Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the stock from $16.00 to $14.00 in a research report on Monday, July 17th. Finally, DA Davidson began coverage on Alcentra Capital Corp. in a research report on Wednesday, July 5th. They set a “buy” rating and a $15.00 price target for the company. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $13.75.
Alcentra Capital Corp. (ABDC) traded down 2.08% during midday trading on Friday, hitting $12.23. The company had a trading volume of 72,772 shares. The stock has a 50 day moving average price of $13.28 and a 200 day moving average price of $13.24. Alcentra Capital Corp. has a 52 week low of $11.17 and a 52 week high of $14.73.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, July 6th. Investors of record on Friday, June 30th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 11.18%. The ex-dividend date of this dividend was Wednesday, June 28th. Alcentra Capital Corp.’s dividend payout ratio is presently 340.00%.
In related news, major shareholder Of New York Mellon Corp Bank sold 1,691,839 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $13.13, for a total value of $22,213,846.07. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 4.96% of the company’s stock.
Institutional investors have recently bought and sold shares of the stock. Muzinich & Co. Inc. raised its position in shares of Alcentra Capital Corp. by 98.3% in the first quarter. Muzinich & Co. Inc. now owns 452,913 shares of the asset manager’s stock valued at $6,223,000 after buying an additional 224,537 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its position in shares of Alcentra Capital Corp. by 93.4% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 166,750 shares of the asset manager’s stock valued at $2,291,000 after buying an additional 80,544 shares during the last quarter. UBS Group AG raised its position in shares of Alcentra Capital Corp. by 20.7% in the first quarter. UBS Group AG now owns 258,940 shares of the asset manager’s stock valued at $3,558,000 after buying an additional 44,387 shares during the last quarter. Mackenzie Financial Corp purchased a new position in shares of Alcentra Capital Corp. during the first quarter valued at about $491,000. Finally, Guggenheim Capital LLC raised its position in shares of Alcentra Capital Corp. by 57.3% in the fourth quarter. Guggenheim Capital LLC now owns 67,654 shares of the asset manager’s stock valued at $810,000 after buying an additional 24,637 shares during the last quarter. 43.58% of the stock is currently owned by hedge funds and other institutional investors.
About Alcentra Capital Corp.
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Alcentra Capital Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Alcentra Capital Corp. and related companies.